Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysisPeter Willeit, Mary Cushman, Rajiv Chowdhury et al.|The Lancet Diabetes & Endocrinology|2016Cited by 224
Reply to Comment on Burger et al. Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials. Atherosclerosis 2024, 396, 118540P.M. Burger, Frank L.J. Visseren, Jannick A N Dorresteijn et al.|Atherosclerosis|2025Cited by 1